We are live on ! Find out more
Tudor Investment Corp

Tudor Investment Corp Portfolio holdings

AUM $53.9B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$4.63B
AUM Growth
+$821M
Cap. Flow
+$1.2B
Cap. Flow %
25.79%
Top 10 Hldgs %
11.83%
Holding
2,869
New
826
Increased
725
Reduced
562
Closed
614

Sector Composition

Rank Sector Weight
1 Technology 16.15%
2 Financials 15.04%
3 Healthcare 11.58%
4 Industrials 10.04%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEXT icon
2176
NextDecade
NEXT
$1.8B
$65K ﹤0.01%
+10,764
New +$71.6K
DSP icon
2177
Viant Technology
DSP
$274M
$63K ﹤0.01%
14,996
+4,984
+50% +$24.4K
LU icon
2178
Lufax Holding
LU
$1.31B
$63K ﹤0.01%
+6,225
New +$106K
IQ icon
2179
iQIYI
IQ
$1.31B
$61K ﹤0.01%
+22,520
New +$83.5K
ATNX
2180
CALL
DELISTED
Athenex, Inc. Common Stock
ATNX
$61K ﹤0.01%
+11,250
New +$116K
ATNX
2181
DELISTED
Athenex, Inc. Common Stock
ATNX
$61K ﹤0.01%
+11,405
New +$117K
ADVM
2182
DELISTED
Adverum Biotechnologies
ADVM
$60K ﹤0.01%
+6,265
New +$82.3K
ELVN icon
2183
Enliven Therapeutics
ELVN
$4.25B
$56K ﹤0.01%
6,126
-6,847
-53% -$40.4K
LCI
2184
DELISTED
Lannett Company, Inc.
LCI
$56K ﹤0.01%
31,063
-746
-2% -$1.63K
OLMA icon
2185
Olema Pharmaceuticals
OLMA
$920M
$55K ﹤0.01%
+19,876
New +$84.3K
RSKD icon
2186
Riskified
RSKD
$863M
$55K ﹤0.01%
+13,914
New +$65.2K
ACTG icon
2187
Acacia Research
ACTG
$449M
$54K ﹤0.01%
+13,409
New +$61.9K
THRN
2188
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$52K ﹤0.01%
10,961
IREN icon
2189
Iris Energy
IREN
$16B
$49K ﹤0.01%
11,799
LTCH
2190
DELISTED
Latch, Inc. Common Stock
LTCH
$48K ﹤0.01%
50,786
AKBA icon
2191
Akebia Therapeutics
AKBA
$241M
$46K ﹤0.01%
146,708
CLSK icon
2192
CleanSpark
CLSK
$2.96B
$41K ﹤0.01%
+12,882
New +$55.7K
GMFIW
2193
CALL
DELISTED
Aetherium Acquisition Corp Warrant
GMFIW
$41K ﹤0.01%
550,000
MIR.WS
2194
CALL
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$37K ﹤0.01%
24,999
GSAT icon
2195
Globalstar
GSAT
$10.7B
$35K ﹤0.01%
1,466
RPID icon
2196
Rapid Micro Biosystems
RPID
$85.3M
$35K ﹤0.01%
+10,760
New +$41.8K
LHDX
2197
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$33K ﹤0.01%
31,002
PSFE icon
2198
Paysafe
PSFE
$405M
$31K ﹤0.01%
1,872
ADERW
2199
CALL
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$31K ﹤0.01%
100,000
AFMD
2200
DELISTED
Affimed
AFMD
$29K ﹤0.01%
+1,413
New +$39.3K

Similar funds

Tudor Investment Corp's Q3 2022 Portfolio in Review

As of Q3 2022, Tudor Investment Corp held 2,869 positions worth $4.63B, up 22% from $3.81B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Tudor Investment Corp deployed $1.2B of net new capital in Q3 2022, opening 826 new positions and adding to 725 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 120,096 shares worth $42.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Warner Bros, an estimated $15.8M trimmed.

  • Tudor Investment Corp's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 120,096 shares worth $42.9M.
  • Tudor Investment Corp added most to EVO Payments, Inc. Class A Common Stock in Q3 2022, an estimated $42.7M increase.
  • Tudor Investment Corp's biggest Q3 2022 reduction was Warner Bros, cutting an estimated $15.8M.
  • Tudor Investment Corp fully exited State Street Energy Select Sector SPDR ETF in Q3 2022, selling an estimated $37.7M.
  • Tudor Investment Corp's ten largest holdings make up 12% of its $4.63B portfolio in Q3 2022.
  • Tudor Investment Corp opened 826 new positions and closed 614 in Q3 2022.
  • Tudor Investment Corp's portfolio value rose 22% quarter-over-quarter to $4.63B.

Based on Tudor Investment Corp's 13F filing for Q3 2022, filed 14 Nov 2022.